Quipt Home Medical (QIPT) Competitors $2.68 +0.01 (+0.19%) As of 09/12/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QIPT vs. TALK, PSNL, SBC, AIRS, EHAB, TOI, LFMD, VMD, XGN, and DCGOShould you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Talkspace (TALK), Personalis (PSNL), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), Enhabit (EHAB), Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), and DocGo (DCGO). These companies are all part of the "healthcare" industry. Quipt Home Medical vs. Its Competitors Talkspace Personalis SBC Medical Group AirSculpt Technologies Enhabit Oncology Institute LifeMD Viemed Healthcare Exagen DocGo Quipt Home Medical (NASDAQ:QIPT) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends. Which has stronger earnings and valuation, QIPT or TALK? Talkspace has lower revenue, but higher earnings than Quipt Home Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuipt Home Medical$245.91M0.48-$6.76M-$0.24-11.21Talkspace$202.61M2.12$1.15M$0.02128.00 Does the media prefer QIPT or TALK? In the previous week, Quipt Home Medical had 1 more articles in the media than Talkspace. MarketBeat recorded 4 mentions for Quipt Home Medical and 3 mentions for Talkspace. Talkspace's average media sentiment score of 1.37 beat Quipt Home Medical's score of 0.80 indicating that Talkspace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quipt Home Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Talkspace 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, QIPT or TALK? Quipt Home Medical has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Do institutionals & insiders believe in QIPT or TALK? 42.9% of Quipt Home Medical shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 13.4% of Quipt Home Medical shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is QIPT or TALK more profitable? Talkspace has a net margin of 1.41% compared to Quipt Home Medical's net margin of -4.30%. Talkspace's return on equity of 2.48% beat Quipt Home Medical's return on equity.Company Net Margins Return on Equity Return on Assets Quipt Home Medical-4.30% -9.78% -4.23% Talkspace 1.41%2.48%2.11% Do analysts recommend QIPT or TALK? Quipt Home Medical currently has a consensus price target of $3.15, indicating a potential upside of 17.10%. Talkspace has a consensus price target of $4.50, indicating a potential upside of 75.78%. Given Talkspace's stronger consensus rating and higher probable upside, analysts plainly believe Talkspace is more favorable than Quipt Home Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quipt Home Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00 SummaryTalkspace beats Quipt Home Medical on 15 of the 17 factors compared between the two stocks. Get Quipt Home Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QIPT vs. The Competition Export to ExcelMetricQuipt Home MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.43M$10.78B$5.85B$10.14BDividend YieldN/A1.84%5.68%4.60%P/E Ratio-11.2121.5175.3425.98Price / Sales0.4829.99514.97181.19Price / Cash2.6424.8137.5660.44Price / Book1.083.5212.156.29Net Income-$6.76M$210.50M$3.29B$271.07M7 Day Performance3.86%-0.18%0.75%3.87%1 Month Performance32.51%1.09%4.82%4.88%1 Year Performance-4.61%-10.96%60.59%26.12% Quipt Home Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QIPTQuipt Home Medical1.9178 of 5 stars$2.69+0.4%$3.15+17.1%-3.6%$116.43M$245.91M-11.211,200TALKTalkspace4.0981 of 5 stars$2.66flat$4.50+69.2%+39.1%$445.46M$187.59M133.07500Positive NewsPSNLPersonalis4.0124 of 5 stars$4.89+2.3%$7.42+51.7%+2.1%$433.63M$84.61M-3.82400News CoverageSBCSBC Medical Group2.0857 of 5 stars$4.08flatN/AN/A$423.83M$205.42M12.75N/ANews CoverageGap UpAIRSAirSculpt Technologies0.6593 of 5 stars$6.45-3.2%$3.75-41.9%+58.2%$402.72M$180.35M-25.80240Positive NewsEHABEnhabit3.1394 of 5 stars$7.90-0.3%$8.67+9.8%+0.8%$399.44M$1.03B-2.9610,700Positive NewsTOIOncology Institute2.9759 of 5 stars$3.40-2.3%$7.00+105.9%+917.0%$317.92M$393.41M-5.00660Positive NewsLFMDLifeMD3.4524 of 5 stars$6.19-4.2%$13.17+112.7%+10.9%$293.51M$212.45M-29.48230Trending NewsInsider TradeVMDViemed Healthcare2.4154 of 5 stars$7.37+1.9%N/A-9.2%$285.85M$224.26M21.681,179Positive NewsXGNExagen4.5842 of 5 stars$9.86+1.2%$11.25+14.1%+223.6%$216.96M$55.64M-11.08220Trending NewsAnalyst UpgradeAnalyst RevisionDCGODocGo2.5066 of 5 stars$1.56-4.3%$3.59+130.1%-56.5%$152.58M$616.55M-8.214,407News CoveragePositive News Related Companies and Tools Related Companies Talkspace Alternatives Personalis Alternatives SBC Medical Group Alternatives AirSculpt Technologies Alternatives Enhabit Alternatives Oncology Institute Alternatives LifeMD Alternatives Viemed Healthcare Alternatives Exagen Alternatives DocGo Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QIPT) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quipt Home Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quipt Home Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
